Terms of Service
“PlexusDX” means PlexusDX LLC, and/or its affiliates (“PlexusDX”, “we”, “us”, “Lab Test Analyzer”). We provide website content, functionality, and other products and services to you when you visit or make purchases at http://www.PlexusDX.com (the “Site”) or remotely through any PlexusDX applications (collectively, the “Services”). “Service” or “Services” includes PlexusDX’s products, software, services, consultations, the mobile app and website (including but not limited to text, graphics, images, and other material and information) as accessed from time to time by the user, regardless of if the use is in connection with an account or not.
PlexusDX provides the Services subject to the following terms and conditions.
By accessing or using the Site or Services, you agree to be bound and abide by these Terms of Service. Please read them with care.
Important information
Compounded medications are not approved by the FDA or reviewed for quality, safety, or efficacy.
Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic®, and Wegovy®.
Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide, identified under the trade names Zepbound® and Mounjaro®.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.